PhotoMedex, Inc. (PHMD), a provider of disease management and aesthetic solutions, Thursday said it raised guidance for the fourth quarter revenue. The company cited better-than-expected performance at the Consumer business segment driven by holiday advertising, and the Physician Recurring and Professional business segments performing well above its view.
The firm said it now expects fourth quarter revenue to be around $52 million and $54 million, 80 percent higher than the same period last year, compared with the previous guidance of between $46 million and $48 million, which was 60 percent above the corresponding prior-year period.
Commenting on the full year's performance and the year ahead, Dolev Rafaeli, chief executive officer of PhotoMedex said, "... For the first time these revenues will exceed $200 million, and at an anticipated range of $218 million to $220 million, represent a gain of more than 65% over last year. We believe the operating initiatives put in place this past year position us well for continued growth in 2013."
For comments and feedback: editorial@rttnews.com